Related Experiment Videos
Hyponatremia induced by oxcarbazepine
1University Clinic of Neurology, Hvidovre Hospital, Copenhagen, Denmark.
Epilepsy Research
|March 1, 1987
Summary
Oxcarbazepine (OxCZ) can cause hyponatremia, a dangerous condition of low sodium levels, leading to symptoms like seizures. Reducing or stopping OxCZ treatment resolved these symptoms, suggesting a direct kidney-related effect.
Area of Science:
- Nephrology
- Endocrinology
- Pharmacology
Background:
- Hyponatremia is a common electrolyte imbalance, often associated with increased morbidity and mortality.
- Antiepileptic drugs, including oxcarbazepine, have been implicated in causing hyponatremia through various mechanisms.
- Water intoxication, a severe form of hyponatremia, can lead to neurological complications.
Observation:
- A patient presented with worsening seizures and lethargy, exhibiting significantly low serum sodium and osmolality levels.
- These clinical and laboratory abnormalities correlated temporally with the initiation and dosage of oxcarbazepine (OxCZ).
Findings:
- Serum sodium and osmolality levels normalized upon reduction and subsequent discontinuation of OxCZ.
- The patient's neurological symptoms, including seizures and lethargy, resolved concurrently with the correction of hyponatremia.
- Low arginine-vasopressin levels were observed, suggesting oxcarbazepine's potential direct or indirect action on renal water handling.
Implications:
- Oxcarbazepine is a potential cause of drug-induced hyponatremia, necessitating careful monitoring of serum electrolytes in patients receiving this medication.
- The findings suggest that oxcarbazepine may interfere with the kidney's ability to regulate water excretion, possibly via arginine-vasopressin pathways.
- This case highlights the importance of considering medication side effects in the differential diagnosis of hyponatremia and seizures.